Fujian Aonong Biological Technology Group Incorporation Limited

SSE:603363.SS

3.77 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 1,783.1221,837.5312,269.4512,241.4742,401.34,270.3515,110.0275,248.7684,817.8616,210.4786,585.1064,662.2764,155.184,716.1435,102.1464,325.8453,894.0274,182.2213,246.7172,339.9891,748.2391,525.3521,551.6611,371.5271,339.541,531.4571,493.2391,381.3021,355.8941,444.4941,194.2011,142.2911,121.6741,501.4751,322.363
Cost of Revenue 1,631.5561,721.442,091.0222,102.7772,451.5424,929.4935,285.4515,506.4784,718.085,767.6095,990.1714,671.0444,235.9745,105.8865,222.0944,184.6363,267.8883,606.7012,736.1231,859.0181,327.221,332.8281,374.6011,200.7331,142.3551,330.4661,283.1111,211.2731,147.8831,203.629965.805910.804897.9321,272.9621,113.701
Gross Profit 151.566116.092178.429138.697-50.242-659.142-175.424-257.7199.782442.869594.935-8.768-80.794-389.743-119.948141.209626.139575.52510.594480.971421.019192.525177.06170.794197.185200.991210.128170.03208.011240.865228.397231.487223.742228.513208.662
Gross Profit Ratio 0.0850.0630.0790.062-0.021-0.154-0.034-0.0490.0210.0710.09-0.002-0.019-0.083-0.0240.0330.1610.1380.1570.2060.2410.1260.1140.1250.1470.1310.1410.1230.1530.1670.1910.2030.1990.1520.158
Reseach & Development Expenses 9.846010.40414.84214.55634.10531.44234.69147.31848.43941.3439.25632.63834.61927.5431.13720.58119.22716.95416.812.37915.00613.76621.95522.12328.49629.66727.1124.4625.8926.14853.3450111.2930
General & Administrative Expenses 84.0280562.043-136.671203.197-356.131410.255-60.569148.714-306.657411.77-91.225154.19-249.907338.329-66.752144.871-134.321118.812-17.67663.833-70.81650.179-19.25941.307-59.72638.523-39.74962.426-145.05968.758-44.14264.953-139.53761.932
Selling & Marketing Expenses 42.1130-269.11361.50571.29290.34789.99893.40686.408113.145111.2498.82889.483106.51676.25182.20873.14580.54162.83850.11953.2655.97548.09970.34879.02997.253100.10798.529106.723126.661107.7108.257108.703121.287117.086
SG&A 126.141-572.597718.682-75.166285.177279.586500.25332.837235.122-193.512523.017.603243.673-143.391414.5815.456218.016-53.78181.64932.443117.093-14.84198.27751.089120.33637.526138.6358.78169.149-18.397176.45864.114173.656-18.251179.018
Other Expenses -211.246-585.539014.842-2.506-773.9278.1578.172-8.142472.576-233.643233.115-9.633-66.01915.4341.9212.301-39.920.62421.698-1.244-3.8930.2571.3052.0050.26-0.073-2.340.444-7.3551.7353.9161.5473.6940.804
Operating Expenses -75.26577.267389.312282.999299.7321,087.619258.427285.702274.298327.503330.707279.974266.679330.139230.048258.414237.84255.128185.643160.957128.888134.902109.5132.501141.184166.278170.476160.066168.295195.68177.941174.689173.101193.926180.47
Operating Income 226.8251,260.264-130.939-256.563-349.974-1,746.761-569.737-740.528-279.956-464.568187.324-458.248-506.862-1,218.017-479.221-406.937297.519202.571258.021262.464242.5668.09835.15611.59623.218-4.92118.882-5.78713.41633.78433.90849.38831.83833.08216.134
Operating Income Ratio 0.1270.686-0.058-0.114-0.146-0.409-0.111-0.141-0.058-0.0750.028-0.098-0.122-0.258-0.094-0.0940.0760.0480.0790.1120.1390.0050.0230.0080.017-0.0030.013-0.0040.010.0230.0280.0430.0280.0220.012
Total Other Income Expenses Net -1.438-256.15-128.347-20.665-26.803-378.2439.9146.41527.912-8.40413.6936.2094.865-5.17315.4341.9212.301-16.1810.62421.698-1.244-3.8930.2571.3052.0050.26-0.073-2.340.444-7.064-1.636-1.2031.5471.8540.804
Income Before Tax 225.3881,004.114-259.286-277.228-376.777-2,125.004-559.823-734.113-252.045-472.972131.974-452.039-501.998-1,252.594-463.787-405.016299.82186.39258.645284.162241.3234.20535.41312.925.223-4.66118.808-8.12813.86126.7235.62753.03133.38534.93516.938
Income Before Tax Ratio 0.1260.546-0.114-0.124-0.157-0.498-0.11-0.14-0.052-0.0760.02-0.097-0.121-0.266-0.091-0.0940.0770.0450.080.1210.1380.0030.0230.0090.019-0.0030.013-0.0060.010.0180.030.0460.030.0230.013
Income Tax Expense 3.717-12.17440.955-2.219-5.15899.542-5.437-5.472-1.580.535-18.315-34.393-15.91134.6192.66-2.398-5.5377.869-1.014-20.26-9.681-17.057-2.781-1.776-1.0011.1373.9221.2813.2979.0895.7636.5815.2535.9010.204
Net Income 218.3051,398.334-278.983-247.986-292.02-2,360.934-480.565-629.611-250.465-473.507150.289-417.646-486.087-1,017.004-340.262-324.63162.02470.714164.359186.854151.062-11.30219.0613.98717.41-1.56614.842.76714.08417.65926.24540.67223.54428.10412.129
Net Income Ratio 0.1220.761-0.123-0.111-0.122-0.553-0.094-0.12-0.052-0.0760.023-0.09-0.117-0.216-0.067-0.0750.0420.0170.0510.080.086-0.0070.0120.0030.013-0.0010.010.0020.010.0120.0220.0360.0210.0190.009
EPS 0.251.61-0.32-0.28-0.34-2.72-0.55-0.72-0.29-0.550.22-0.61-0.73-1.53-0.53-0.50.250.110.250.330.27-0.0190.0230.0060.031-0.0020.0230.0050.0250.0360.0540.0930.0540.0540.023
EPS Diluted 0.251.61-0.32-0.28-0.34-2.72-0.55-0.72-0.29-0.550.22-0.61-0.7-1.53-0.53-0.50.220.110.220.330.27-0.0180.0230.0060.031-0.0020.0230.0050.0250.0360.0540.0930.0540.0540.023
EBITDA 261.881,260.264-143.02478.344-126.295-1,433.794-134.156-618.446222.136-360.621592.24718.595-24.489-837.273-40.195-118.031617.638270.304321.121320.33274.33645.48960.93937.50243.88647.95336.724-4.26456.17930.00357.17448.07250.64123.57532.729
EBITDA Ratio 0.1470.686-0.0630.035-0.053-0.336-0.026-0.1180.046-0.0580.090.004-0.006-0.178-0.008-0.0270.1590.0650.0990.1370.1570.030.0390.0270.0330.0310.025-0.0030.0410.0210.0480.0420.0450.0160.025